Amalgamated Bank’s Apyx Medical APYX Stock Holding History

Amalgamated Bank’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,094	Closed	-$33K	–	3037
2022 Q1	$33K	Buy	+5,094	New	+$50.2K	﹤0.01%	2640

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Amalgamated Bank's APYX Position: Q2 2022 in Review

Amalgamated Bank sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 5,094 shares — an estimated $33K sold.

Amalgamated Bank first reported a position in APYX in Q1 2022 and held it in 1 quarter. The position peaked at $33K in Q1 2022. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Amalgamated Bank reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 5,094 Apyx Medical shares in Q2 2022, an estimated $33K.
Amalgamated Bank first reported a position in Apyx Medical in Q1 2022 and held it in 1 quarter.
Amalgamated Bank's Apyx Medical position peaked at $33K in Q1 2022.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.